CIK 0001582313
- Large accelerated filer
Xenon Pharmaceuticals Inc.
Sign in to watch- Ticker
- XENE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- EIN
- 980661854
- Phone
- +1 604-484-3300
- Business address
- 200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
- Open-market buys, last 90 days
- $1,681,140
- in 2 filings
- Open-market sales, last 90 days
- $425,829
- in 1 filing, $426K under 10b5-1 plans
Net +$1,255,311. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-11 | EMPFIELD JAMES R. EVP, Drug Discovery | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2023-03-10 | EMPFIELD JAMES R. EVP, Drug Discovery | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2022-08-12 | EMPFIELD JAMES R. EVP, Drug Discovery | Exercise or conversion | +20,000 | $3.10 | $62K | 30,000 |
| 2022-08-12 | EMPFIELD JAMES R. EVP, Drug Discovery | Exercise or conversion | +45,000 | $4.75 | $214K | 75,000 |
| 2022-08-12 | EMPFIELD JAMES R. EVP, Drug Discovery | Shares withheld for taxes | −7,257 | $38.02 | $276K | 67,743 |
| 2022-08-12 | EMPFIELD JAMES R. EVP, Drug Discovery | Sale | −35,868 | $38.08 | $1.4M | 31,875 |
| 2022-08-12 | EMPFIELD JAMES R. EVP, Drug Discovery | Sale | −21,875 | $38.68 | $846K | 10,000 |
| 2022-08-12 | EMPFIELD JAMES R. EVP, Drug Discovery | Exercise or conversion · Stock Option (Right to Buy) | −20,000 | 0 | ||
| 2022-08-12 | EMPFIELD JAMES R. EVP, Drug Discovery | Exercise or conversion · Stock Option (Right to Buy) | −45,000 | 0 | ||
| 2022-03-10 | EMPFIELD JAMES R. EVP, Drug Discovery | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2022-03-07 | EMPFIELD JAMES R. EVP, Drug Discovery | Exercise or conversion | +2,500 | $8.40 | $21K | 12,500 |
| 2022-03-07 | EMPFIELD JAMES R. EVP, Drug Discovery | Shares withheld for taxes | −695 | $30.23 | $21K | 11,805 |
| 2022-03-07 | EMPFIELD JAMES R. EVP, Drug Discovery | Exercise or conversion | +40,000 | $6.76 | $270K | 51,805 |
| 2022-03-07 | EMPFIELD JAMES R. EVP, Drug Discovery | Shares withheld for taxes | −8,952 | $30.23 | $271K | 42,853 |
| 2022-03-07 | EMPFIELD JAMES R. EVP, Drug Discovery | Sale | −1,805 | $30.62 | $55K | 41,048 |
| 2022-03-07 | EMPFIELD JAMES R. EVP, Drug Discovery | Sale | −31,048 | $30.54 | $948K | 10,000 |
| 2022-03-07 | EMPFIELD JAMES R. EVP, Drug Discovery | Exercise or conversion · Stock Option (Right to Buy) | −2,500 | 0 | ||
| 2022-03-07 | EMPFIELD JAMES R. EVP, Drug Discovery | Exercise or conversion · Stock Option (Right to Buy) | −40,000 | 0 | ||
| 2022-03-04 | EMPFIELD JAMES R. EVP, Drug Discovery | Exercise or conversion | +25,000 | $8.40 | $210K | 35,000 |
| 2022-03-04 | EMPFIELD JAMES R. EVP, Drug Discovery | Shares withheld for taxes | −6,685 | $31.42 | $210K | 28,315 |
Page 1 of 2 · 25 trades